Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha S

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Journal of Cancer Research and Clinical Oncology|April 8, 2023
Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicityMalek Shatila, Weijie Ma, Yantong Cui, et al.
Neurosurgical Focus|October 1, 2020
Frailty predicts worse outcomes after intracranial meningioma surgery irrespective of existing prognostic factorsBrianna C Theriault, Julia Pazniokas, Anusha S Adkoli, et al.
Journal of Cancer|October 20, 2023
The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic ReviewAntonio Pizuorno Machado, Hunter Ratliff, Ahmed Abdelwahab, et al.
Cancers|June 28, 2023
Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and ProctopathyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2021
Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related EsophagitisKavea Panneerselvam, Rajan N Amin, Dongguang Wei, et al.
Therapeutic Advances in Medical Oncology|February 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapyAndrew G Kuang, Malek Shatila, Jay S Shah, et al.
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Journal of Cancer|October 2, 2023
Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated ColitisAntonio Pizuorno Machado, Malek Shatila, Enrico N De Toni, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapyBhanu B Prakash, Prahlad H Yathiraj, T Krishna Sharan, et al.
American Journal of Clinical Oncology|June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal InfectionsWeijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|April 8, 2023
Effects of immunosuppressive treatment on patient outcomes after immune checkpoint inhibitor-related gastrointestinal toxicityMalek Shatila, Weijie Ma, Yantong Cui, et al.
Neurosurgical Focus|October 1, 2020
Frailty predicts worse outcomes after intracranial meningioma surgery irrespective of existing prognostic factorsBrianna C Theriault, Julia Pazniokas, Anusha S Adkoli, et al.
Journal of Cancer|October 20, 2023
The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic ReviewAntonio Pizuorno Machado, Hunter Ratliff, Ahmed Abdelwahab, et al.
Cancers|June 28, 2023
Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and ProctopathyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2021
Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related EsophagitisKavea Panneerselvam, Rajan N Amin, Dongguang Wei, et al.
Therapeutic Advances in Medical Oncology|February 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapyAndrew G Kuang, Malek Shatila, Jay S Shah, et al.
Journal of Cancer|July 21, 2023
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with CancerCynthia Liu, Malek Shatila, Antony Mathew, et al.
Journal of Cancer|October 2, 2023
Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated ColitisAntonio Pizuorno Machado, Malek Shatila, Enrico N De Toni, et al.
Journal of Cancer Research and Therapeutics|June 7, 2019
Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapyBhanu B Prakash, Prahlad H Yathiraj, T Krishna Sharan, et al.
American Journal of Clinical Oncology|June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal InfectionsWeijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Pageof 9